Niki BioSolutions, Inc. (NIKI) Current Assets (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Current Assets came in at $221685.0 in Q4 2025, up 61.95% on a QoQ basis from $136889.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Current Assets (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 9 years of Current Assets data on file, last reported at $221685.0 in Q4 2025.

Quarterly Current Assets changed N/A year-over-year to $221685.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $221685.0 (changed N/A YoY) and the FY2025 annual result came in at $3.6 million, up 274.4% from the prior year.
Current Assets advanced to $221685.0 in Q4 2025, from $136889.0 in the prior quarter.
In the past five years, Current Assets ranged from a high of $21.9 million in Q2 2021 to a low of $103485.0 in Q2 2025.
A 5-year average of $5.6 million and a median of $2.2 million in 2023 frame the typical range for Current Assets.
Annual changes were most pronounced in 2021 — Current Assets soared 257.67% — and 2023, when it slumped 79.65%.
Tracing NIKI's Current Assets over 5 years: stood at $12.7 million in 2021, then tumbled by 44.3% to $7.1 million in 2022, then tumbled by 64.97% to $2.5 million in 2023, then slumped by 88.7% to $279696.0 in 2024, then decreased by 20.74% to $221685.0 in 2025.
The last three Current Assets figures came in at $221685.0 (Q4 2025), $136889.0 (Q3 2025), and $103485.0 (Q2 2025), per Business Quant data.

Download Data